Wonder if we close the gap or not?
3 year EBIT CGAR is 12.2 percent. Last year was an anomaly boosted by govt and single drug.
Anywhere between 5-10 percent is good. I reckon it will be closer to high single digits unless new expensive drug gets on the PBS.